Abstract

The article presents the state of cardiovascular system of smokers with different period of tobacco smoking. From, the result of our studies, we can conclude that smoking tobacco results in a significant increase in heart rate, systolic blood pressure, a significant reduction in P, PQ and QT times, an insignificant increase in diastolic blood pressure and a decrease in QRS duration.1 Background: Tobacco smoking is one of the most important risk factors of coronary heart disease (CHD). Hence, smoking cessation is considered pivotal in the prevention of CHD. The current study aimed to evaluate smoking cessation patterns and determine factors associated with smoking cessation in patients with established CHD.

• 1.   Centres for Disease Control and Prevention (CDC). Smoking-attributable mortality, years of potential life lost, and productivity losses–United States, 2000–2002
• 2.   Robinson SH Smoking and drinking among adults, 2009: a report on the 2009 General Lifestyle Survey, 2011 Office for National Statistics H
• 3.   Perk Scholte op Reimer WJ, Vrints C, Wood D, ZamoranoJL,Zannad F. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR), \Eur Heart J, 2012, vol. 33 (pg. 1635-1701)
• 4.   Kotseva K, Wood D, De Backer G, De BacquerD,Porala K, Keil U. Cardiovascular prevention guidelines in daily practice: a comparison of Euroaspire I, II, and III surveys in eight European countries, Lancet, 2009, vol 373(pg. 929-940)
• 5.   Puranik R, CelermajerDS.Smoking and endothelial function, Prog Cardiovasc Dis, 2003 vol. 45(pg. 443- 458)
• 6.   WHO Report on the global tobacco epidemic, 2008: the mpower package, 2008 Geneva World Health Organization
• 7.   Centers for Disease C. Prevention Current cigarette smoking among adults: United States, 2011, MMWR Morb Mortal Wkly Rep, 2012, vol. 61 (pg. 889-894)
• 8.   Shinton G. Meta-analysis of relation between cigarette smoking and stroke, BMJ, 1989, vol. 298 (pg. 789-794)
• 9.   Celermajer DS, Sorensen KE, Georgakopoulos D, Bull, Thomas O, Robinson J, Deanfield JE. Cigarette smoking is associated with dose-related and potentially reversible impairment of endotheliumdependent dilation in healthy young adults, Circulation, 1993, vol. 885 Pt 1(pg. 2149-2155)
• 10.   Hoffman SJ, Mammone J, Rogers Van Katwyk S, et al. Cigarette consumption estimates for 71 countries from 1970 to 2015: systematic collection of comparable data to facilitate quasi-experimental evaluations of national and global tobacco control interventions.
• 11.   Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corra U, Cosyns B, Deaton C, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation.
• 12.   Thompson S.C., Nedkoff L., Katzenellenbogen J.K., Hussain M.A., Frank Sanfilippo F. Challenges in Managing Acute Cardiovascular Diseases and Follow Up Care in Rural Areas.

Data Sharing Statement

Funding